Evolución tras la retirada de la oxigenoterapia domiciliaria. Perfil del paciente en el que hay que reintroducirla

Lourido-Cebreiro, Tamara; González-Barcala, Francisco J; Rábade, Carlos; Abelleira-Paris, Romina; Pereiro-Brea, Tara; Valdés, Luis.
Arch. bronconeumol. (Ed. impr.) ; 55(12): 663-665, dic. 2019. tab
Artículo en Español | IBECS (España) | ID: ibc-186409

Documentos relacionados

  1. [Development and Application of Medical Device Recall Event Tracking System].
  2. <i>Analysis</i>: Using the FDA MAUDE and Medical Device Recall Databases to Design Better Devices.
  3. Research: Evaluation of Orthopedic Hip Device Recalls by the FDA from 2007 to 2017.
  4. Medical Device Recalls in Orthopedics: Recent Trends and Areas for Improvement.
  5. Association Between Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510(k) Clearance.
  6. New Philips BiPAP Recall.
  7. Use of Recalled Devices in New Device Authorizations Under the US Food and Drug Administration's 510(k) Pathway and Risk of Subsequent Recalls.
  8. MEDICAL DEVICE RECALLS IN CANADA FROM 2005 TO 2015.
  9. Risk of Recall for Total Joint Arthroplasty Devices Over 10 Years.
  10. Performing in-center titration studies amid the Philips Respironics medical device recall.